The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...
The Department of Defense's Defense Health Agency has awarded a $2,433,748 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "DECISION SUPPORT TOOLS ADDRESSING TRAUMATIC BRAIN INJURY IN BRIDGE (STAT-BRIDGE)", aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $1,437,598 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, effective September 1, 2024 through August 31, 2027, will fund the "TRANSFORMING RESEARCH AND CLINICAL KNOWLEDGE IN TRAUMATIC BRAIN INJURY: CONCUSSION OUTCOME AND RECOVERY PREDICTION SCORE (TRACK-TBI: CORPS)" project. This research initiative aims...
The Regents of the University of California, San Francisco (UCSF) received a $860,998 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research focused on neurophysiology and the development of biomarkers for post-traumatic epilepsy. The award period runs from April 1, 2025 to March 31, 2028. UCSF, a prominent academic medical center and research institution, will...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The Regents of the University of California, San Francisco, a prominent academic medical center and research institution, will conduct innovative scientific investigations spanning...
This $2,699,157 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research initiative focused on evaluating the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The project will be conducted by the University of Pittsburgh, a prominent public research university,...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
This $6,214,900 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the Scintillon Institute to investigate the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The 4-year award, effective from November 1, 2024 to October 31, 2028, will enable the Scintillon Institute to conduct advanced biomedical research...
The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...